| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |